CCEA approves Rs 3,300 cr FDI by Reckitt for Paras buy

A meeting of the CCEA held here cleared the proposal of Reckitt Benckiser Plc to set up a new, wholly owned subsidiary investing company with a foreign equity of 100 per cent to make a downstream investment to fully acquire Paras Pharma.

"The approval is expected to result in foreign direct investment (FDI) amounting to Rs 3,300 crore approximately in the wholly-owned subsidiary of Reckitt Benckiser Plc UK," an official statement said

In December last year, Reckitt Benckiser had agreed to fully acquire Ahmedabad-based Paras Pharmaceuticals Ltd for Rs 3,260 crore.

The shares of the new subsidiary will be 100 per cent subscribed by Reckitt Benckiser (Singapore) (entire equity except 10 shares) and R&C Nominees Limited (10 shares), it added.

Paras Pharma is a privately-owned firm with a portfolio of leading over-the-counter health and personal care brands including, Moov, D'Cold, Dermicool, Krack, Itch Guard and Ring Guard.

It also has a personal care business led by Set Wet, a leading hair gel and deodorant brand.Reckitt Benckiser had acquired the firm as to expand its business in India.

Narendra Modi or Rahul Gandhi? Who will win the battle royale of the Lok Sabha Elections 2019


Get real-time news updates, views and analysis on Lok Sabha Elections 2019 on Deccanherald.com/news/lok-sabha-elections-2019 


Like us on Facebook or follow us on Twitter and Instagram with #DHPoliticalTheatre for live updates on the Indian general elections 2019.

Liked the story?

  • 0

    Happy
  • 0

    Amused
  • 0

    Sad
  • 0

    Frustrated
  • 0

    Angry